Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

WF-10 fails to meet primary endpoints in phase III AIDS study

July 20, 2004

European approval for Telzir for HIV

July 20, 2004

Antiviral efficacy of a saquinavir-based HAART regimen in HIV-infected patients

July 20, 2004

Antiviral activity of a 2-5A agonist in cells from HIV-positive patients

July 19, 2004

First patients enrolled in phase I trial of new HIV vaccine

July 19, 2004

Integrase inhibitor boosts cellular immunity to suppress HIV-1 replication in monkeys

July 19, 2004

Tibotec discloses antiinfective compounds

July 16, 2004

MIV-150 as a vaginal microbicide for HIV-infected women

July 16, 2004

Statins reported to reduce HIV-1 replication

July 16, 2004

(PE)HRG214 reduces viral load in HIV-infected patients

July 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....